Monoclonal antibody ipilimumab and receptor. Illustration of two molecules of the monoclonal antibody ipilimumab (green and blue) bound to the human protein receptor CTLA-4 (yellow) on a cell membrane (across bottom). Monoclonal antibody therapy aims to activate the immune system, in this case by targeting this CTLA-4 checkpoint inhibitor to allow the body to respond to and destroy a wide range of cancers. The development of ipilimumab was part of the work that led to the award of the 2018 Nobel Prize in Physiology or Medicine. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Andrade, Ramon / 3dciencia |
Bildgröße: | 3620 px × 4827 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |